Moreover, in experimental animal models of MRSA endocarditis and cefalosporin-resistant pneumococcal meningitis, fosfomycin and b-lactam (or vancomycin) combinations have proved to be superior than monotherapies, preventing the emergence of drug-resistant populations as well.